These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 28137551
1. Bromocriptine Induces Autophagy-Dependent Cell Death in Pituitary Adenomas. Geng X, Ma L, Li Z, Li Z, Li J, Li M, Wang Q, Chen Z, Sun Q. World Neurosurg; 2017 Apr; 100():407-416. PubMed ID: 28137551 [Abstract] [Full Text] [Related]
5. Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine. Li Q, Su Z, Liu J, Cai L, Lu J, Lin S, Xiong Z, Li W, Zheng W, Wu J, Zhuge Q, Wu Z. Mol Cell Endocrinol; 2014 Jan 25; 382(1):377-384. PubMed ID: 24184771 [Abstract] [Full Text] [Related]
6. The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas. Wang S, Wang A, Zhang Y, Zhu K, Wang X, Chen Y, Wu J. BMC Endocr Disord; 2021 Nov 23; 21(1):235. PubMed ID: 34814904 [Abstract] [Full Text] [Related]
7. Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell lines. Wang X, Du Q, Mao Z, Fan X, Hu B, Wang Z, Chen Z, Jiang X, Wang Z, Lei N, Wang H, Zhu Y. Oncotarget; 2017 Jul 11; 8(28):45874-45887. PubMed ID: 28501857 [Abstract] [Full Text] [Related]
10. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas. Jones TH, Figueroa CD, Smith CM, Bhoola KD. Agents Actions Suppl; 1992 Jul 11; 38 ( Pt 2)():175-82. PubMed ID: 1462825 [Abstract] [Full Text] [Related]
13. Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas. Bai J, Gui S, Zhang Y. J Clin Neurosci; 2013 May 11; 20(5):721-5. PubMed ID: 23523357 [Abstract] [Full Text] [Related]
15. Involvement of bone morphogenetic protein-4 in GH regulation by octreotide and bromocriptine in rat pituitary GH3 cells. Miyoshi T, Otsuka F, Otani H, Inagaki K, Goto J, Yamashita M, Ogura T, Iwasaki Y, Makino H. J Endocrinol; 2008 Apr 11; 197(1):159-69. PubMed ID: 18372242 [Abstract] [Full Text] [Related]
16. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors. Barrow DL, Tindall GT, Kovacs K, Thorner MO, Horvath E, Hoffman JC. J Neurosurg; 1984 Jan 11; 60(1):1-7. PubMed ID: 6689702 [Abstract] [Full Text] [Related]
17. Bromocriptine treatment reduces the cell size in human macroprolactinomas: a morphometric study. Bassetti M, Spada A, Pezzo G, Giannattasio G. J Clin Endocrinol Metab; 1984 Feb 11; 58(2):268-73. PubMed ID: 6693536 [Abstract] [Full Text] [Related]
18. Induction of apoptosis in rat somatotrophin-secreting pituitary adenoma cells by bromocriptine. Yin D, Kondo S, Takeuchi J, Morimura T. Oncol Res; 1993 Feb 11; 5(9):383-7. PubMed ID: 8038459 [Abstract] [Full Text] [Related]
19. DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma. Yao H, Tang H, Zhang Y, Zhang QF, Liu XY, Liu YT, Gu WT, Zheng YZ, Shang HB, Wang Y, Huang JY, Wei YX, Zhang X, Zhang J, Wu ZB. Cancer Lett; 2019 Sep 10; 459():135-144. PubMed ID: 31176743 [Abstract] [Full Text] [Related]
20. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma. De Leo V, Petraglia F, Sardelli S, Danero S, Genazzani AR, D'Antona N. Obstet Gynecol; 1987 Jan 10; 69(1):99-103. PubMed ID: 3099236 [Abstract] [Full Text] [Related] Page: [Next] [New Search]